Detalles de la búsqueda
1.
Aspirin vs Placebo as Adjuvant Therapy for Breast Cancer: The Alliance A011502 Randomized Trial.
JAMA
; 331(20): 1714-1721, 2024 May 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38683596
2.
Treatment against glucose-dependent cancers through metabolic PFKFB3 targeting of glycolytic flux.
Cancer Metastasis Rev
; 41(2): 447-458, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35419769
3.
HALT-D: a randomized open-label phase II study of crofelemer for the prevention of chemotherapy-induced diarrhea in patients with HER2-positive breast cancer receiving trastuzumab, pertuzumab, and a taxane.
Breast Cancer Res Treat
; 196(3): 571-581, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36280642
4.
Molecular characterization of ESR1 variants in breast cancer.
Breast Cancer Res Treat
; 196(2): 279-289, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36125660
5.
Hematologic safety of palbociclib in combination with endocrine therapy in patients with benign ethnic neutropenia and advanced breast cancer.
Cancer
; 127(19): 3622-3630, 2021 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34157782
6.
Long-term follow-up assessment of cardiac safety in SAFE-HEaRt, a clinical trial evaluating the use of HER2-targeted therapies in patients with breast cancer and compromised heart function.
Breast Cancer Res Treat
; 185(3): 863-868, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33400034
7.
Chemotherapy-related amenorrhea (CRA) after adjuvant ado-trastuzumab emtansine (T-DM1) compared to paclitaxel in combination with trastuzumab (TH) (TBCRC033: ATEMPT Trial).
Breast Cancer Res Treat
; 189(1): 103-110, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34120223
8.
Actionable co-alterations in breast tumors with pathogenic mutations in the homologous recombination DNA damage repair pathway.
Breast Cancer Res Treat
; 184(2): 265-275, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32776290
9.
Rebound lymphocytosis in a patient with chronic lymphocytic leukemia after cessation of a CDK 4/6 inhibitor for concomitant breast cancer.
Breast J
; 26(10): 2031-2033, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32639043
10.
Characteristics and outcomes of breast cancer patients enrolled in the National Cancer Institute Cancer Therapy Evaluation Program sponsored phase I clinical trials.
Breast Cancer Res Treat
; 168(1): 35-41, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-29119354
11.
Adjuvant platinum-based chemotherapy for early stage cervical cancer.
Cochrane Database Syst Rev
; 11: CD005342, 2016 11 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-27873308
12.
Incidence and Mitigation of Corneal Pseudomicrocysts Induced by Antibody-Drug Conjugates (ADCs).
Curr Ophthalmol Rep
; 12(2): 13-22, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38756824
13.
Co-clinical Trial of Novel Bispecific Anti-HER2 Antibody Zanidatamab in Patient-Derived Xenografts.
Cancer Discov
; 14(5): 828-845, 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38358339
14.
A phase I trial of palbociclib and bosutinib with fulvestrant in patients with metastatic hormone receptor positive and HER2 negative (HR+ HER2-) breast cancer refractory to an aromatase inhibitor and a CDK4/6 inhibitor.
Contemp Clin Trials Commun
; 33: 101110, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37026029
15.
Propagated Circulating Tumor Cells Uncover the Potential Role of NFκB, EMT, and TGFß Signaling Pathways and COP1 in Metastasis.
Cancers (Basel)
; 15(6)2023 Mar 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36980717
16.
Protein signaling and drug target activation signatures to guide therapy prioritization: Therapeutic resistance and sensitivity in the I-SPY 2 Trial.
Cell Rep Med
; 4(12): 101312, 2023 12 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38086377
17.
Adjuvant platinum-based chemotherapy for early stage cervical cancer.
Cochrane Database Syst Rev
; (6): CD005342, 2012 Jun 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-22696349
18.
Chemobrain in Breast Cancer: Mechanisms, Clinical Manifestations, and Potential Interventions.
Drug Saf
; 45(6): 601-621, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35606623
19.
Cardiac outcomes of subjects on adjuvant trastuzumab emtansine vs paclitaxel in combination with trastuzumab for stage I HER2-positive breast cancer (ATEMPT) study (TBCRC033): a randomized controlled trial.
NPJ Breast Cancer
; 8(1): 18, 2022 Feb 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-35173164
20.
An evaluation of palbociclib as a breast cancer treatment option: a current update.
Expert Opin Pharmacother
; 22(3): 281-290, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33198527